Literature DB >> 15284713

Decreased breast cancer tumor size, stage, and mortality in Rhode Island: an example of a well-screened population.

Natalie G Coburn1, Maureen A Chung, John Fulton, Blake Cady.   

Abstract

BACKGROUND: Since the 1980s, Rhode Island has achieved one of the highest mammography screening rates in the nation. The objective of this study was to determine the effect of high mammography rates on breast cancer presentation and outcomes.
METHODS: Using the Rhode Island Cancer Registry, the incidence of DCIS and invasive cancer, tumor size, stage, rate of BCS and mortality from breast cancer were determined from 1987 to 2001.
RESULTS: Over 80% of Rhode Island women report routine mammography. From 1987 to 2001, there were 1,660 cases of DCIS and 11,301 cases of invasive breast cancer. Although the overall incidence of invasive cancer was stable, the median diameter decreased from 2 cm to 1.5 cm with a significant decrease in the incidence of stage III and IV cancers. There was an increase in BCS for women 50 to 64 years of age with stage I and II disease and for women older than 65 years with stage I disease. Disease-specific mortality decreased by 25%.
CONCLUSIONS: High mammography rates in Rhode Island are associated with smaller and earlier-stage breast cancers. This largely accounts for the decreased mortality from breast cancer and the increased rate of BCS.

Entities:  

Mesh:

Year:  2004        PMID: 15284713     DOI: 10.1177/107327480401100403

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  14 in total

1.  Biological, Medical, and Other Tissue Variables Affecting Biospecimen Utilization.

Authors:  Dennis Otali; Sameer Al Diffalha; William E Grizzle
Journal:  Biopreserv Biobank       Date:  2019-06       Impact factor: 2.300

2.  Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.

Authors:  Armando E Giuliano; Linda McCall; Peter Beitsch; Pat W Whitworth; Peter Blumencranz; A Marilyn Leitch; Sukamal Saha; Kelly K Hunt; Monica Morrow; Karla Ballman
Journal:  Ann Surg       Date:  2010-09       Impact factor: 12.969

3.  False Positive Reduction by an Annular Model as a Set of Few Features for Microcalcification Detection to Assist Early Diagnosis of Breast Cancer.

Authors:  Jonathan Hernández-Capistrán; Jorge F Martínez-Carballido; Roberto Rosas-Romero
Journal:  J Med Syst       Date:  2018-06-18       Impact factor: 4.460

4.  Dedicated 3D photoacoustic breast imaging.

Authors:  Robert A Kruger; Cherie M Kuzmiak; Richard B Lam; Daniel R Reinecke; Stephen P Del Rio; Doreen Steed
Journal:  Med Phys       Date:  2013-11       Impact factor: 4.071

5.  Do not jump too quickly to conclusions.

Authors:  Daniel B Kopans
Journal:  Breast Cancer Res       Date:  2012-07-23       Impact factor: 6.466

Review 6.  Advanced breast cancer incidence following population-based mammographic screening.

Authors:  P Autier; M Boniol; R Middleton; J F Doré; C Héry; T Zheng; A Gavin
Journal:  Ann Oncol       Date:  2011-01-20       Impact factor: 32.976

7.  Screening prior to Breast Cancer Diagnosis: The More Things Change, the More They Stay the Same.

Authors:  Erica B Friedman; Jennifer Chun; Freya Schnabel; Shira Schwartz; Sidney Law; Jessica Billig; Erin Ivanoff; Linda Moy; Deborah Axelrod; Amber Guth
Journal:  Int J Breast Cancer       Date:  2013-09-18

8.  Assessment of breast cancer opportunistic screening by clinical-pathological indicators: a population-based study.

Authors:  A Bordoni; N M Probst-Hensch; L Mazzucchelli; A Spitale
Journal:  Br J Cancer       Date:  2009-10-27       Impact factor: 7.640

9.  Imaging-assisted large-format breast pathology: program rationale and development in a nonprofit health system in the United States.

Authors:  F Lee Tucker
Journal:  Int J Breast Cancer       Date:  2012-12-17

10.  Ductal carcinoma in situ of the breast: a surgical perspective.

Authors:  Mohammed Badruddoja
Journal:  Int J Surg Oncol       Date:  2012-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.